Exos Asset Management LLC - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Exos Asset Management LLC ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q2 2022$356,000
-21.9%
36,318
-22.5%
0.18%
-5.1%
Q1 2022$456,000
+3.9%
46,862
+3.4%
0.20%
-13.7%
Q4 2021$439,000
+0.2%
45,3000.0%0.23%
-2.2%
Q3 2021$438,000
-0.7%
45,3000.0%0.23%
+0.9%
Q2 2021$441,00045,3000.23%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Exos Asset Management LLC 45,300$441,0000.23%
MMCAP International Inc. SPC 250,000$2,435,0000.12%
Atalaya Capital Management LP 40,000$386,0000.10%
Radcliffe Capital Management, L.P. 200,000$1,942,0000.06%
Arena Capital Advisors, LLC- CA 75,000$731,0000.06%
FIR TREE CAPITAL MANAGEMENT LP 150,000$1,449,0000.05%
Athanor Capital, LP 147,800$1,428,0000.05%
Woodline Partners LP 275,000$2,654,0000.05%
Ghisallo Capital Management LLC 125,000$1,208,0000.05%
SUVRETTA CAPITAL MANAGEMENT, LLC 300,000$2,922,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders